These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
296 related articles for article (PubMed ID: 3545090)
1. Antinuclear and anti-single-stranded DNA antibodies in morphea and generalized morphea. Falanga V; Medsger TA; Reichlin M Arch Dermatol; 1987 Mar; 123(3):350-3. PubMed ID: 3545090 [TBL] [Abstract][Full Text] [Related]
2. Prevalence and characteristics of anti-single-stranded DNA antibodies in localized scleroderma. Comparison with systemic lupus erythematosus. Ruffatti A; Peserico A; Rondinone R; Calligaro A; Del Ross T; Ghirardello A; Germino M; Todesco S Arch Dermatol; 1991 Aug; 127(8):1180-3. PubMed ID: 1863075 [TBL] [Abstract][Full Text] [Related]
3. Anti-agalactosyl immunoglobulin G antibodies in localized scleroderma. Mimra Y; Ihn H; Jinnin M; Asano Y; Yamane K; Yazawa N; Tamaki K Int J Dermatol; 2005 Oct; 44(10):817-20. PubMed ID: 16207181 [TBL] [Abstract][Full Text] [Related]
4. Serum autoantibodies and their clinical associations in patients with childhood- and adult-onset linear scleroderma. A single-center study. Arkachaisri T; Fertig N; Pino S; Medsger TA J Rheumatol; 2008 Dec; 35(12):2439-44. PubMed ID: 19004036 [TBL] [Abstract][Full Text] [Related]
5. "Borrelia-associated early-onset morphea": a particular type of scleroderma in childhood and adolescence with high titer antinuclear antibodies? Results of a cohort analysis and presentation of three cases. Prinz JC; Kutasi Z; Weisenseel P; Pótó L; Battyáni Z; Ruzicka T J Am Acad Dermatol; 2009 Feb; 60(2):248-55. PubMed ID: 19022534 [TBL] [Abstract][Full Text] [Related]
6. Anti-DNA topoisomerase IIalpha autoantibodies in localized scleroderma. Hayakawa I; Hasegawa M; Takehara K; Sato S Arthritis Rheum; 2004 Jan; 50(1):227-32. PubMed ID: 14730620 [TBL] [Abstract][Full Text] [Related]
7. Antigen specificity of antihistone antibodies in localized scleroderma. Sato S; Fujimoto M; Ihn H; Kikuchi K; Takehara K Arch Dermatol; 1994 Oct; 130(10):1273-7. PubMed ID: 7524451 [TBL] [Abstract][Full Text] [Related]
9. Soluble CD4 and CD8 in serum from patients with localized scleroderma. Sato S; Fujimoto M; Kikuchi K; Ihn H; Tamaki K; Takehara K Arch Dermatol Res; 1996 Jun; 288(7):358-62. PubMed ID: 8818182 [TBL] [Abstract][Full Text] [Related]
10. Autoantibodies against matrix metalloproteinase-1 in patients with localized scleroderma. Tomimura S; Ogawa F; Iwata Y; Komura K; Hara T; Muroi E; Takenaka M; Shimizu K; Hasegawa M; Fujimoto M; Sato S J Dermatol Sci; 2008 Oct; 52(1):47-54. PubMed ID: 18565735 [TBL] [Abstract][Full Text] [Related]
11. Anti-ssDNA and antinuclear antibodies in human malaria. Adu D; Williams DG; Quakyi IA; Voller A; Anim-Addo Y; Bruce-Tagoe AA; Johnson GD; Holborow EJ Clin Exp Immunol; 1982 Aug; 49(2):310-6. PubMed ID: 6982135 [TBL] [Abstract][Full Text] [Related]
12. [The antinuclear antibody spectrum in circumscribed forms of scleroderma]. do Vale E; Gerstmeier H; Meurer M; Krieg T; Braun-Falco O Dtsch Med Wochenschr; 1986 Dec; 111(50):1922-7. PubMed ID: 3536401 [TBL] [Abstract][Full Text] [Related]
14. Selective detection of autoimmune antibodies to single- and double-stranded DNA by enzyme immunoassay. Makowski GS; Ramsby ML Ann Clin Lab Sci; 2003; 33(2):142-8. PubMed ID: 12817617 [TBL] [Abstract][Full Text] [Related]
15. Morphea in adults and children cohort III: nested case-control study--the clinical significance of autoantibodies in morphea. Dharamsi JW; Victor S; Aguwa N; Ahn C; Arnett F; Mayes MD; Jacobe H JAMA Dermatol; 2013 Oct; 149(10):1159-65. PubMed ID: 23925398 [TBL] [Abstract][Full Text] [Related]
16. [Presence of the antinuclear antibodies and antibodies to Borrelia burgdorferi among patients with morphea en plaque, deep linear scleroderma and atrophoderma Pasini-Pierini]. Wojas-Pelc A; Wielowieyska-Szybińska D; Kiełtyka A Przegl Lek; 2002; 59(11):898-902. PubMed ID: 12715718 [TBL] [Abstract][Full Text] [Related]